Exparel 133 MG/10 ML vial 10ML

Ended Awarded Last action

Contract number
SPE2DR26FHVM8
Awardee
Awarding agency
Obligated
$6,165

Award facts

Contract value 100% obligated
$6,164.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 3, 2026, for Exparel 133 mg/10 ml vials with a ceiling value of $6,164.60 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

PPV-G GEN V is the DLA's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. The order carries firm fixed pricing. DMS Pharmaceutical Group Inc. is a woman-owned small business.

Quick answers

Who was awarded contract SPE2DR26FHVM8?

SPE2DR26FHVM8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 3, 2026.

How much is contract SPE2DR26FHVM8 worth?

The government has obligated $6,165 on SPE2DR26FHVM8.

Is contract SPE2DR26FHVM8 an order under another contract?

Yes. SPE2DR26FHVM8 is a delivery order under SPE2DR25D9768, an indefinite delivery contract.

Was contract SPE2DR26FHVM8 competed?

The extent of competition for SPE2DR26FHVM8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login